FeRx: Magnetically targeted drug delivery

For the vast majority of cancer patients, long-term chemotherapy and radiation remain their best options despite years of research and resources that have been dedicated not only to combating the disease, but to eliminating, or at least minimizing, the traumatic and toxic effects of chemotherapy.

FeRx Inc. has developed a drug delivery technology called Magnetic Targeted Carriers (MTCs), which it believes can provide increased therapeutic effect while limiting the debilitating toxicity of nonspecific systemic exposure resulting from chemotherapy...